Oncology

Registrations

from 03/02/2021 to 05/20/2021
from 07/19/2021 to 07/26/2021

More Information

Total Estimated Investment

International Student 4000€ *2

CPLP Students 2200€ *2

European Student 1250€ *2

Description

This course provides solid training in the fundamentals of Oncology, with a strong component in the areas of biology, (epi)genetics and pathology, addressing the epidemiological, clinical and therapeutic dimensions of Cancer in light of current knowledge about its molecular bases. The course also intends to provide
students with the knowledge, skills and aptitudes necessary for the development of research activity in Oncology, namely biostatistics methods. Allied to the theoretical-practical component, students have privileged contact with the laboratory and clinical contexts.

This program presents levels of demand and excellence, with the supervision of clinical or translational research projects being carried out by professors and researchers in the field of Oncology of recognized national and international merit.

For whom?

Degree or legal equivalent in Medicine, Dentistry, Veterinary Medicine, Biology, Biochemistry, Pharmaceutical Sciences, Nursing, Psychology, Health Technologies and other degrees or legal equivalent in the area of ​​health sciences with an interest in oncology.

Why this master?

The course aims to contribute to a solid training based on current knowledge derived from basic and clinical research in Oncology. It addresses issues ranging from the development of cancer, its genetic linkage and the molecular basis of therapy.

Professional Opportunities

The Program is aimed at young graduates in the areas of biological and health sciences with motivation and ambition to develop skills to carry out fundamental, translational, and clinical research in Oncology.

Partnerships

Porto Comprehensive Cancer Center (Porto.CCC, a consortium established between IPO Porto and i3S) and RISE – Health Research Network (Associated Laboratory that brings together research units from the Faculty of Medicine of the University of Porto and the Faculty of Medicine of Porto University of Lisbon, the Research Center of the IPO Porto and researchers from NOVA Medical School, the Porto School of Nursing and the University of Aveiro) which, in addition to other areas of human health, also includes a line of research in Oncological diseases, as well as laboratories of other organic units of the University of Porto.

Programme

1st semester (Year 1)
Oncobiology
Methodologies and Statistics I
Clinical Oncology
Epidemiology
Laboratory Oncology
Option 1: Experimental Carcinogenesis, Imunology and Cancer, Psycho-oncology
2nd semester (Year 1)
Oncologic Pathology
Project – Research Seminars
Supervised Laboratory / Clinical Practice
Research Methodologies in Biostatistics II
Epigenetics
Option 2: Pharmacogenomics, Cancer Screening & Prevention, Molecular Signalling, Xenobiotics and Cancer
3rd semester (Year 2)
Monitoring Seminars
Dissertation / Internship
4th semester (Year 2)
Dissertation / Internship
1st semester (Year 1)
Oncobiology
Methodologies and Statistics I
Clinical Oncology
Epidemiology
Laboratory Oncology
Option 1: Experimental Carcinogenesis, Imunology and Cancer, Psycho-oncology
2nd semester (Year 1)
Oncologic Pathology
Project – Research Seminars
Supervised Laboratory / Clinical Practice
Research Methodologies in Biostatistics II
Epigenetics
Option 2: Pharmacogenomics, Cancer Screening & Prevention, Molecular Signalling, Xenobiotics and Cancer
3rd semester (Year 2)
Monitoring Seminars
Dissertation / Internship
4th semester (Year 2)
Dissertation / Internship

Contact us

Rua de Jorge Viterbo Ferreira,
228 4050-313 Porto
Portugal

TESTIMONIALS

Prof. Carmen Jerónimo

“This is a master’s degree with a multidisciplinary and multidimensional character, promoting a critical scientific interpretation of students. In addition to being
composed of a highly qualified faculty, this Master’s
has a privileged connection with an international
reference center (IPO-Porto), giving students the
opportunity to take classes in a hospital environment
in the different areas of clinical oncology, in contact
direct with clinical practice in oncology. It is, therefore,
an asset for those who want to specialize in this area.”